PharmAbcine signs a license agreement with Wincal Biopharm to expand indications of…
PharmAbcine announced that the company entered into a license agreement with Wincal Biopharm, a wholly owned US subsidiary of PharmAbcine, so that Wincal can expand the commercial value…
Read More...
Read More...